Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

priority access

This page shows the latest priority access news and features for those working in and with pharma, biotech and healthcare.

NHS England says yes to Roche's Hemlibra

NHS England says yes to Roche's Hemlibra

which has ensured access to emicizumab for patients with inhibitors with limited treatment options.”. ... Hemlibra's market access was agreed outside the normal framework of NHS England's specialised commissioning, which ranks treatments and procedures

Latest news

  • Amgen gets prevention claim for cholesterol drug Repatha Amgen gets prevention claim for cholesterol drug Repatha

    Amgen CEO Robert Bradway said a few weeks ago that “improving patient access to Repatha remains a top priority for our team”, adding that the cardiovascular outcomes data will be a ... With this approval, it's now more important than ever that

  • GSK tops Access to Medicines Index for fifth time running GSK tops Access to Medicines Index for fifth time running

    Only 5% of products covered by pricing strategies currently meet affordability criteria in priority access countries, according to the 2016 Index, despite companies increasingly waiving patent rights in priority regions. ... The Access to Medicines Index

  • Ready for takeoff? Ready for takeoff?

    The most popular of the early access options is the Adaptive Pathway Pilot Programme, a precursor to PRIME. ... All sectors within the pharmaceutical industry will benefit from greater access to innovative new medicines across the EU.

  • AstraZeneca embarks on oncology research access project AstraZeneca embarks on oncology research access project

    Users of the Repositive platform can quickly and easily access human genomic data from a wide range of sources, making it ideal for improving data discovery and access.”. ... Contributors will benefit from early access to the resource and any

  • Cell Therapy licenses heart failure therapy in Japan Cell Therapy licenses heart failure therapy in Japan

    The accelerated regulatory pathway for regenerative medicines in Japan enables faster patient access, making it a natural priority for us," said Reginald, adding that having Daiichi Sankyo on board will allow

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • OUTiCO Case Study - Product Launch

    POSITIVE FORMULARY SUCCESS WITHIN 8 MONTHS! CHALLENGE. New product launch. Limited market access capabilities in priority CCG/Health Boards. ... Short time frame to gain positive formulary positioning. SOLUTION. OUTiCO intelligence used to prioritise key

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Quick links

Infographics

Multimedia